J. Chem. Sci. (2018) 130:88
Page 3 of 9 88
study (m/z = 599.3 for C36H52MnN2O2) (A1/A2) and UV- MHz, CDCl3) δ 7.44 (d, J = 7.5 Hz, 4H), 7.41–7.35 (m,
Vis spectroscopy (λmax = 440 nm and 510 nm) (A1/A2).
2.4 General procedure for benzylic chlorination
4H), 7.32 (q, J = 7.1 Hz, 2H), 6.16 (s, 1H).
2.4g Methyl 2-(4-(1-chloro-2-methylpropyl)phenyl)
propane (4): Compound 4 was obtained from ibuprofen
methyl ester 3, isolated by column chromatography (hex-
NaOCl (0.66 M, 4 mL) was added to a solution of [Mn(Salen)
X] (2 mol%) catalyst, tetrabutylammonium chloride (TBACl,
5 mol%), substrate (2 mmol) in dichloromethane in a 10 mL
sealed vial. Here, TBACl acts as phase transfer catalyst and
NaOCl is oxidant and chlorinating source. This mixture was
stirred smoothly under a nitrogen atmosphere at room tem-
perature and carried out for 12 h. Then the reaction mixture
was extracted with CH2Cl2 and water to remove the catalyst
and unreacted NaOCl. The solution was analyzed by GC/MS.
The yield was calculated with respect to reactant added.
1
ane/ethyl acetate). H NMR (400 MHz, CDCl3) δ 1H NMR
(400 MHz, CDCl3) δ 7.31–7.28 (m, 2H), 7.28–7.25 (m, 2H),
4.62 (d, J = 7.6 Hz, 1H), 3.72 (q, J = 7.2 Hz, 1H), 3.66 (s,
3H), 2.22 (dq, J = 13.5, 6.7 Hz, 1H), 1.49 (d, J = 7.2 Hz,
3H), 1.10 (d, J = 6.6 Hz, 3H), 0.87 (d, J = 6.7 Hz, 3H). 13C
NMR (101 MHz, CDCl3) δ 175.1, 140.3, 140.1, 127.9, 127.6,
70.7, 52.3, 45.3, 36.8, 20.4, 19.7, 18.7. HRMS [ESI, (+) ve]:
calcd. for (C14H19ClNaO2) 277.0962, found 277.0966.
2.4a Benzyl chloride (2b)18: Compound 2b was obtai-
ned from toluene 1b, isolated by column chromatography
2.5 Preparation of oxidized [Mn(salen)]+ complex
for ESI-MS and UV-Vis study
1
(hexane/ether). H NMR (500 MHz, CDCl3) δ 7.40 (t, J =
5.4 Hz, 3H), 7.38–7.31 (m, 2H), 4.61 (s, 2H).
In the CH2Cl2 solution of complex A1/A2 (0.3 × 10−3 M),
50 fold of excess NaOCl was added and shaken vigorously
at room temperature, after 15 s the color of the solution
changed from orange-brown to green. Then, it was imme-
diately subjected to UV-Vis spectroscopy. For ESI-MS study,
to the CH2Cl2 solution of complex A1 (10−3 M), 15 fold of
excess NaOCl was added and shaken vigorously for a minute
at room temperature, then directly used for ESI-MS study at
a different time.
2.4b 1-bromo-4-(chloroethyl)-benzene (2c): Compo-
und 2c was obtained from 1-bromo-4-ethylbenzene 1c, iso-
lated by column chromatography (hexane/ethyl acetate).
1HNMR (400 MHz, CDCl3) δ 7.48 (m, 2H), 7.3 (m, 2H),
5.04 (q, 1H), 1.83 (d, 3H). 13C NMR (101 MHz, CDCl3) δ
142.0, 131.1, 128.4, 122.3, 58.0, 26.6.
2.4c 4-(chloromethyl)-1,1ꢀ-biphenyl (2d): Compound
2d was obtained from 4-methyl-1,1ꢀ-biphenyl 1d, isolated
by column chromatography (hexane/ethyl acetate). 1H NMR
(400 MHz, CDCl3) δ 7.65–7.58 (m, 4H), 7.51–7.45 (m, 4H),
7.38 (ddd, J = 7.3, 3.8, 1.1 Hz, 1H), 4.66 (s, 2H). 13C NMR
(101 MHz, CDCl3) δ 141.6, 140.7, 136.7, 129.3, 129.0, 127.7,
127.7, 127.3, 46.3.
2.6 Kinetic study
A stock solution of complex A2 (1.5×10−4 M) was prepared
in CH2Cl2. To this solution 50 equivalent of excess NaOCl
was added and shaken vigorously at 0 ◦C to get the green color
solution. Then 4 mL of this solution was taken and 1 mmol of
ethylbenzene was added and immediately subjected to time-
dependent UV-Vis study. The spectra were recorded in every
5 s. The rate constant for decay of Mn(V)=O complex was
determined from time trace at λmax, 640 nm which shows an
exponential decay pattern. Kinetic data analysis showed that
this decay followed a pseudo-first order reaction in presence
of excess substrate with decay rate constant k1 = 4.94 ×
2.4d 4ꢀ-methyl-[1,1ꢀ-biphenyl]-2-carbonitrile (2e):
Compound 2e was obtained from 4ꢀ-methyl-[1, 1ꢀ- biphenyl]-
2-carbonitrile 1e, isolated by column chromatography (hex-
1
ane/ethyl acetate) H NMR (400 MHz, CDCl3) δ 7.77 (d,
J = 7.7 Hz, 1H), 7.72–7.61 (m, 2H), 7.59–7.54 (m, 2H), 7.52
(dd, J = 5.3, 3.0 Hz, 2H), 7.46 (td, J = 7.7, 1.1 Hz, 1H),
4.65 (s, 1H).13C NMR (101 MHz, CDCl3) δ 144.9, 138.4,
138.1, 134.0, 133.1, 130.2, 129.4, 129.3, 129.1, 128.0, 126.8,
118.8, 111.4, 45.9.
10−2 s−1
.
2.7 EPR study to detect the formation of MnIV (salen)
complex
2.4e (1-chloromethyl)naphthalene (2f): 19 Compound
2f was obtained from 1-methyl naphthalene 1f, isolated by
column chromatography (hexane/ethyl acetate). 1H NMR
(500 MHz, CDCl3) δ 8.16 (d, J = 8.4 Hz, 1H), 7.88 (dd,
J = 17.0, 8.2 Hz, 2H), 7.61 (t, J = 7.6 Hz, 1H), 7.57–7.52
(m, 2H), 7.47–7.41 (m, 1H), 5.07 (s, 2H).
A solution of MnIII(salen) [complex A1 (10 mM)] in 2.5 mL
of CH2Cl2 was prepared. To this solution, 5 equiv. of PhIO
was added and the solution was stirred for 5 min. When the
colour of the solution changed from brown to dark green, 10
equiv. of ethylbenzene (substrate) was added. The solution
2.4f (Chloromethylene)-dibenzene (2g): Compound was shaken for a few seconds and an aliquot of 250 μL of this
2g was obtained from diphenyl methane 1g, isolated by col- solution was transferred to an EPR tube, frozen at 100 K and
1
umn chromatography (hexane/ethyl acetate) H NMR (500 the EPR spectrum of this solution was recorded.